Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ware Branch

Showing results (161-170 of 167) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 167 results.
Annals of the Rheumatic Diseases|November 20, 2025
Clinical and biologic predictors of thrombosis in persistently antiphospholipid antibody-positive patients: Prospective analysis of the International APS ACTION Clinical Database and Repository ('Registry')Jonathan Thaler, Michael Parides, Danieli Castro Oliveira de Andrade, et al.
Arthritis Care & Research|February 3, 2025
Predictors of Mortality in Antiphospholipid Antibody-Positive Patients: Prospective Results From Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking Clinical Database and RepositoryYasaman Ahmadzadeh, Larry S Magder, Danieli Castro Oliveira de Andrade, et al.
Clinical and Experimental Rheumatology|July 30, 2025
Antiphospholipid antibody-related clinical manifestations during childhood versus adulthood: descriptive results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) clinical database and repositoryJheel Pandya Bhatt, Marissa Dale, Danieli Castro Oliveira de Andrade, et al.
Advances in Rheumatology (London, England)|April 17, 2026
Do ethnoracial differences exist among antiphospholipid antibody-positive patients with no other systemic autoimmune diseases: results from the APS ACTION registryElena Gkrouzman, Alicia Matijasevich, Carolina Bonilla Richero, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 28, 2023
The 2023 ACR/EULAR Antiphospholipid Syndrome Classification CriteriaMedha Barbhaiya, Stephane Zuily, Ray Naden, et al.
Annals of the Rheumatic Diseases|August 28, 2023
2023 ACR/EULAR antiphospholipid syndrome classification criteriaMedha Barbhaiya, Stephane Zuily, Ray Naden, et al.
The Lancet. Rheumatology|January 22, 2024
Global comment on the use of hydroxychloroquine during the periconception period and pregnancy in women with autoimmune diseasesKaren Schreiber, Ian Giles, Nathalie Costedoat-Chalumeau, et al.
Pageof 17

Showing results (161-170 of 167) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 167 results.
Annals of the Rheumatic Diseases|November 20, 2025
Clinical and biologic predictors of thrombosis in persistently antiphospholipid antibody-positive patients: Prospective analysis of the International APS ACTION Clinical Database and Repository ('Registry')Jonathan Thaler, Michael Parides, Danieli Castro Oliveira de Andrade, et al.
Arthritis Care & Research|February 3, 2025
Predictors of Mortality in Antiphospholipid Antibody-Positive Patients: Prospective Results From Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking Clinical Database and RepositoryYasaman Ahmadzadeh, Larry S Magder, Danieli Castro Oliveira de Andrade, et al.
Clinical and Experimental Rheumatology|July 30, 2025
Antiphospholipid antibody-related clinical manifestations during childhood versus adulthood: descriptive results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) clinical database and repositoryJheel Pandya Bhatt, Marissa Dale, Danieli Castro Oliveira de Andrade, et al.
Advances in Rheumatology (London, England)|April 17, 2026
Do ethnoracial differences exist among antiphospholipid antibody-positive patients with no other systemic autoimmune diseases: results from the APS ACTION registryElena Gkrouzman, Alicia Matijasevich, Carolina Bonilla Richero, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 28, 2023
The 2023 ACR/EULAR Antiphospholipid Syndrome Classification CriteriaMedha Barbhaiya, Stephane Zuily, Ray Naden, et al.
Annals of the Rheumatic Diseases|August 28, 2023
2023 ACR/EULAR antiphospholipid syndrome classification criteriaMedha Barbhaiya, Stephane Zuily, Ray Naden, et al.
The Lancet. Rheumatology|January 22, 2024
Global comment on the use of hydroxychloroquine during the periconception period and pregnancy in women with autoimmune diseasesKaren Schreiber, Ian Giles, Nathalie Costedoat-Chalumeau, et al.
Pageof 17